Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
Date:1/28/2010

mp;A expenses, as a percentage of net sales, increased to 9% for the first nine months of Fiscal 2010, as compared to 4% for the corresponding period of Fiscal 2009. The higher percentage of SG&A is partly due to the lower sales in the current period versus the corresponding period last year.

Total R&D expenses incurred for the third quarter and first nine months of Fiscal 2010 were $2.8 million and $8.3 million respectively, as compared to $5.8 million and $16.9 million, respectively, during the corresponding periods of Fiscal 2009. The R&D expenses during the first nine months of Fiscal 2010 were lower compared to those during the corresponding period of Fiscal 2009 as we were reimbursed a certain amount relating to certain product litigation costs during the second quarter of Fiscal 2010, as part of a settlement agreement, as previously disclosed. Although R&D expenses have decreased in the current period due to the focus of the Company on remediating FDA concerns, they are likely to increase once the company refocuses on new product filings and approvals with the FDA.

Caraco filed two Abbreviated New Drug Applications ("ANDAs") relating to two products with the FDA during the first nine months of Fiscal 2010. The Company has not received FDA approval for any ANDAs during the first nine months of Fiscal 2010 and does not expect to receive any approvals for products out of its Michigan facilities until resolution of the FDA's concerns. The total number of ANDAs pending approval by the FDA as of December 31, 2009 was 31 (including four tentative approvals) relating to 27 products.  

As previously disclosed, the FDA has initiated certain actions and, as a consequence, production at the Company's Mich
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
2. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
3. Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation
4. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) Tablets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action Lawsuits
9. Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation
10. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
11. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 The Elizabeth Glaser Pediatric ... and the U.S. President’s Emergency Plan for AIDS Relief ... significant new milestones in the global effort to eliminate ... announced that as of June 2013, one million babies ... Since PEPFAR’s inception in 2003, EGPAF has been ...
(Date:6/18/2013)... 2013 Two months ago, Suyima Torres, 28, ... for a second session of a silicone treatment for gluteus ... treatment was allegedly performed by a mystery Venezuelan doctor in ... According to Dr. Bernabe Vazquez of Bayshore Cosmetic Surgery ... from doctor’s who are not board certified is more common ...
(Date:6/18/2013)... A new $119 million industry is ... industry is redefining the way consumers get their seafood. ... personal culinary chefs on the Emerald Coast panhandle of ... seafood and the promising industry of aquaculture. , The ... consumers strive to fully partake in the effort, especially ...
(Date:6/18/2013)... New York (PRWEB) June 18, 2013 As ... both state and federal court, a new report has revealed ... than 70,000 U.S. Food & Drug Administration (FDA) adverse event ... to NewsChannel5 in Cleveland, Ohio, over 4.700 Mirena users have ... while more than 1,300 have reportedly experienced uterine perforations due ...
(Date:6/18/2013)... New York magazine named 145 physicians from ... Doctors” list, up from 129 last year and more than ... also lists 52 additional doctors who serve at hospitals within ... trajectory. The “Best Doctors” issue, which this year features a ... issue and is available online at http://www.nymag.com/bestdoctors . , ...
Breaking Medicine News(10 mins):Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3
... of Minnesota cancer surgeon and researcher has found a ... the earliest stage of breast cancer choosing to have ... prophylactic mastectomy (CPM) surgery among U.S. women with ductal ... 1998 and 2005, according to Todd Tuttle, M.D., lead ...
... out and destroys tumor cells, researchers say , , FRIDAY, ... virus can target and kill breast cancer stem cells, ... be effective against cancer stem cells, because we have ... cancer cells," Dr. Patrick Lee, a cancer researcher at ...
... Case Timer Solves Widespread ProblemST. LOUIS, April 10 There ... and children are the fastest growing segment. The contact ... growing under those lenses. , , ... fusarium keratitis and acanthamoeba keratitis. These are nasty words ...
... has been promoted to the position of Service Area ... Baron Center, Inc (BCI). Dr. Tau is a ... forensic psychology. Dr. Tau is an expert in assessing ... has been extensively used as a workplace violence and ...
... [Brown University] Nursing homes serving primarily Hispanic ... whose patients were mostly white, according to Brown ... Journal of the American Medical Directors Association ... at the rate of bed sores at nursing ...
... and critical care specialists at Johns Hopkins have begun to ... intensive care unit (ICU) that leads so many patients to ... study reported online April 10 in Critical Care Medicine ... depression six months after hospitalization among very sick ICU patients, ...
Cached Medicine News:Health News:More women with early stage breast cancer choosing double mastectomies 2Health News:Harmless Virus May Be Deadly to Breast Cancer 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 3Health News:Manny Tau, Psy.D. Promoted to Service Area Leader for the Problematic Behaviors Service Area at Baron Center, Inc 2Health News:Hispanics appear to face poorer quality nursing home care 2Health News:In the ICU, use of benzodiazepines, other factors may predict severity of post-stay depression 2
(Date:6/18/2013)... June 18, 2013 Today, Wall Street ... GILD ), Health Management Associates Inc. (NYSE: ... ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and ... reports free of charge - including full price targets, industry ... Gilead Sciences, Inc. Research Report On June ...
(Date:6/18/2013)... , June 18, 2013  Pro football player and ... and professional family expert Jo Frost have ... Specialty L.P., the fully integrated specialty pharmaceutical business of ... awareness of this significant health problem. In recognition of ... and Drug Administration (FDA) approval of EpiPen ® ...
(Date:6/17/2013)... AUSTIN, Texas , June 17, 2013  Hanger, ... new 5-year credit agreement that increases its senior secured ... from $400 million previously.  The new credit agreement includes ... million term loan facility.  The previous credit agreement was ... a $300 million term loan.  Each new facility matures ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... The ADC CLIA Waived Drug Tests are ... and Read. They demonstrate excellent correlation with ... preliminary positive results in minutes instead of ... waived certified laboratories in clinics, physician offices ...
ThyroTest by ThyroTec, Inc. is a rapid immunoassay, similar to a rapid pregnancy test. By using 2 drops of blood from a finger stick and 5 drops of diluent, a qualitative TSH level is inicated in min...
... Contact Lens Comfort Drops improve comfort on contact ... contact lenses from your disinfecting system or from ... your finger and place one or two drops ... it in your eyethe lens will go in ...
Medicine Products: